About Sakar
Key Milestones / History
Mission, Vision & Values
Management Desk
Rewards and Recognition
Business
Facility
Exports
Research and Development
Quality
Future Plans
Corporate Social responsibility
General Product
Oral - Liquid Syrup & Suspension
Liquid Injectable (SVP)-Vials & Ampoules
Cephalosporin - Dry Powder Injections
Cephalosporin – Oral Solid
Lyophilised Injections (In Vials)
Oncology Product
Oral (Tablet, Capsule, Granules & Liquid)
Liquid Injection
Lyophilised Injection
Active Pharmaceutical Ingredient(API)
CDMO Products
CRAMs
Clients
Investor Relations
Financial Reports (Quarterly & Annually)
Quarterly
Financial Results
Investor Presentation
Earnings audio Call Recording
Earnings Call transcript
Shareholding Pattern (Quarterly)
Press Release
Earnings call Invite
Factsheet (Quarterly/Annually)
Annual
Annual Reports
Subsidiary financials
Quarterly
Annually
Board of Directors
Board of Directors and Small description
Committees
Shareholder’s Information
Share price information from BSE & NSE
Notices & Intimations
Corporate Announcements
Shareholder’s Meet / AGM
Credit Rating
Policies
Corporate Governance
Corporate Governance
Appointment of committee members, Key Managerial positions
Documents related to Corporate governance, Compliance
Board of Directors
Board of Directors and Small description
Event Calendar
Investor Support
Registrar, Company Secretary and Transfer Agent Information
Grievance Redressal
Reverse Enquiry Toolkit
News & Awards
Rewards and Recognition
Careers
Contact
Corporate Governance Report
Corporate Governance Report
CGR-Q3 - December 2024
CGR-Q2 –September 2024
CGR-Q1 –June 2024
CGR-Q4 – March 2024
CGR-Q3 – December 2022
CGR-Q2 – September 2022
CGR-Q1 - June 2022
CGR-Q4 - March 2022
CGR-Q3 - December 2021
CGR-Q2 - September 2021
CGR-Q1 - June 2021
CGR-Q4 - March 2021
CGR-Q3 - Dec 2020
CGR-Q2 - Sept 2020
CGR-Q1 - June 2020
CGR-Q4 - March 2020
CGR-Q3 - Dec 2019
CGR-Q2 - Sept 2019
CGR-Q1 - June 2019
